Apparatus and method for subcutaneous electrode insertion

- Cameron Health, Inc.

Devices and methods for electrode implantation. A first embodiment includes an electrode insertion tool adapted to tunnel through tissue and attach, at its distal end, to a lead, such that the lead may be pulled into the tunneled space as the electrode insertion tool is removed. Additional embodiments include methods for inserting electrode/lead assemblies, including a method wherein an insertion tool is first used to tunnel through tissue, then to pull an electrode/lead into the tunneled space. In a further embodiment the insertion tool is next used, with a splittable sheath disposed thereon, to create an additional path into tissue, after which the insertion tool is removed, leaving the sheath in place; a lead is inserted to the sheath, and, finally, the splittable sheath is removed over the lead.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
FIELD

The present invention is related to the field of medical treatments including electrode implantations. More particularly, the present invention is related to the field of electrode implantation or insertion for cardiac treatments.

BACKGROUND

The use of implantable pacing and defibrillation devices to treat or prevent various cardiac problems has become relatively widespread. Several difficulties with such treatments relate to placement and durability of electrodes. Typically, well practiced, careful and gentle maneuvers are required during insertion to avoid breaking the leads and/or electrodes. Once placed, leads may fracture after being subjected to repeated stresses as the heart beats and the patient moves. Leads and electrodes may also migrate from their desired position.

For transvenous implantation, a lead is typically introduced by advancing it through a vein to a location in or near the heart with the aid of fluoroscopy. The lead is then anchored to heart tissue or a passive anchor mechanism such as tines are utilized to prevent the lead from moving. The heart tissue will tend to form around the lead, attenuating sensed signals as well as altering pacing and/or defibrillating thresholds. Because implantation requires traversing the vasculature as well as placement and anchoring within the heart, many problems can arise.

Many lead insertion techniques push a lead into place into tissue or through the vasculature. Pushing the lead stresses the lead and can cause lead failure. With vascular implantations, the pathway is defined but is subject to constrictions and tight turns. Non-vascular implantation calls for tunneling through existing tissue. While extra stiffness may help with lead insertion and aid accurate lead placement, stiffer leads create their own problems with migration, perforation, and fracture. As stiffness increases, the ability of the lead to inadvertently perforate tissue rises. Further, with extra stiffness, the lead does not rest in place during muscle movement, tending to increase the size of any associated fibroid, and potentially leading to migration.

SUMMARY

The present invention, in a first embodiment, includes a tool for implanting a lead electrode assembly. The tool may include a handle and a relatively stiff shaft having a proximal end and a distal end, with the handle secured to the proximal end of the shaft. The distal end of the shaft includes an attachment feature which can be used to attach to a lead electrode assembly. The attachment feature, in use, allows the tool to be secured to the lead electrode assembly after it is advanced through tissue. Once so secured, the tool enables pulling or pushing of the lead electrode assembly through the portion of tissue that has already been tunneled by the tool.

The shaft may also define a lumen extending distally from a port or hub (such as a Luer hub) in the handle. The shaft may then include a fluid infusion port for infusing a fluid forced through the lumen into tissue during an implantation procedure. In an illustrative method embodiment, the fluid infusion port and lumen are used to infuse a local anesthetic such as lidocaine during an implantation.

The attachment feature may take the form of a suture hole allowing a suture to be passed therethrough. In a preferred embodiment, the fluid infusion port opens into a suture hole. The shaft may be straight, may include a curve, or may define an arc of curvature. In one embodiment, the shaft is provided with a curvature that mimics the curvature of a patient's lower ribcage. The shaft may also be shapeable such that a user can adapt the shaft to the shape of a selected portion of anatomy such as a patient's ribcage.

In another embodiment, an electrode insertion tool kit is provided, the tool kit including a tool for inserting an electrode and a splittable sheath for use in conjunction with the tool. The tool may have one or more of the features noted above. The splittable sheath is preferably sized to snugly fit over the tool. The kit may also include more than one insertion tool, one being straight and one having a curved shape, as well as an infusion tubing set for coupling to the one or more insertion tools, and a shaping tool for re-shaping or modifying the shape of an insertion tool.

Further embodiments include methods for inserting electrodes and leads to a patient subcutaneously. In one such embodiment, first and second incisions are made at spaced apart locations. An insertion tool having proximal and distal ends is inserted via the first incision and advanced subcutaneously toward the second incision. The distal end of the insertion tool may be passed out through the second incision. An electrode/lead assembly is then attached to the distal end of the insertion tool, and the insertion tool is withdrawn via the same path it was inserted through. As the insertion tool is withdrawn, the electrode/lead assembly is pulled subcutaneously into the patient. An alternative embodiment does not include passing the distal end of the insertion tool out of the second incision, instead only passing the distal end proximate the incision such that the electrode/lead assembly may be attached thereto.

In a further embodiment, the insertion tool is completely withdrawn through the first incision until the portion of the electrode/lead assembly connected to the insertion tool is pulled through the first incision. Then the insertion tool is inserted via the first incision and advanced subcutaneously in a direction different from the direction of the second incision. Preferably, the insertion tool is advanced in a direction that is at a significant angle with respect to a line along which the first and second incisions lie. The insertion tool is then removed and the electrode/lead assembly advanced through the path defined by the insertion tool.

In yet a further embodiment, the insertion tool, at least during the second insertion through the first incision, is inserted with a sheath placed thereover. Once the insertion tool and sheath are inserted to a desired extent, the insertion tool is removed, leaving the sheath in place. Then the electrode/lead assembly is inserted into the sheath to a desired extent. Finally, the sheath is removed. Preferably the sheath includes a line of axial weakness, or is a splittable sheath, so that it can be removed over the electrode/lead assembly without damaging or moving the assembly.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates in perspective view an electrode insertion tool kit including several components;

FIGS. 2A-2B show, in perspective and section views, a straight electrode insertion tool;

FIGS. 3A-3B show, in perspective and section views, a curved electrode insertion tool;

FIGS. 4A-4C show detailed section views of an electrode insertion tool handle;

FIGS. 5A-5B show, in perspective and section views, details of an electrode insertion tool tip;

FIGS. 6A-6C show perspective and alternative detail views of a lead electrode assembly;

FIG. 7 shows a perspective view of an insertion tool bending device;

FIG. 8 shows a perspective partial view of an infusion tubing set;

FIGS. 9A-9B show, in combination and alone, an insertion tool with a splittable sheath and a splittable sheath by itself;

FIG. 10 shows a patient illustrating relative positions for illustrative incisions;

FIGS. 11A-11J show an illustrative method of electrode insertion; and

FIGS. 12A-12B illustrate several aspects of different sensor configurations.

 DETAILED DESCRIPTION

The following detailed description should be read with reference to the drawings. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.

It should be noted that the terms “lead” and “lead electrode assembly” as used herein carry distinct meanings, with a lead electrode assembly being a lead and electrode coupled together. U.S. patent application Ser. No. 09/940,377 to Bardy et al., now U.S. Pat. No. 6,866,044, is incorporated herein by reference. Bardy et al. suggest several methods for insertion of a defibrillator device including a subcutaneous canister and electrode(s), and explain additional details of subcutaneous defibrillation devices and methods.

FIG. 1 illustrates in perspective view a lead electrode assembly insertion tool kit including several components. The kit 10 includes a number of items, including a straight insertion tool 20, a curved insertion tool 40, a bending tool 100 and an infusion tubing set 110. The kit 10 may further include a splittable sheath (not shown) such as that illustrated in FIGS. 9A-9B. In several illustrative embodiments, the insertion tools 20, 40 include elongate shafts made of stainless steel tubes, with plastic handles, although other materials may be used as desired for either portion. The infusion tubing set 110 will often include a flexible polymeric tubular member, although this is not required. The bending tool 100 may be used to adjust the shape of the insertion tools 20, 40, although again this is not required. Features of each of these elements are further explained below.

FIGS. 2A-2B show, in perspective and section views, a straight electrode insertion tool. Referring to FIG. 2A, the tool 20 is generally straight distal of its handle 26, and includes a shaft portion 22 that is preferably stiff enough to provide pushability to a distal end 24 for creating a path through tissue. In several embodiments, a relatively rigid metallic member, such as a stainless steel shaft, is used for the shaft portion 22. The shaft 22 is secured to a handle 26 near its proximal end, where a Luer connector 28 is provided.

The distal end 24 of the shaft 22 illustrates a number of attachment features, including a groove 30 and a suture hole 32. For example, the groove 30 may be a radial groove allowing for slipknot attachment to a thread such as a suture. The suture hole 32 may allow for a thread or suture to be passed therethrough and then tied. The end of the tool might also possess specific geometries for attachment to specific electrode designs.

Referring to FIG. 2B, the tool 20 is shown in a cut-away or section view, with the shaft 22 extending through the handle 26. The shaft 22 defines a lumen 34 that extends from the Luer connector 28 to an infusion port opening into the suture hole 32. The handle 26 may be secured to the shaft 22 in any suitable manner, for example, with adhesives, mechanical securing devices (i.e., mating threads, notches, or the like), heat welding, or by overmolding the handle 26 onto the shaft 22. One way to provide additional mechanical strength to any such attachment is to include an offset bend 36 in the shaft 22 under the handle 26.

FIGS. 3A-3B show, in perspective and section views, a curved electrode insertion tool. The features are generally similar to those of FIGS. 2A-2B. Referring to FIG. 3A, the tool 40 has a gradual or smooth curve which may be selected or shaped to match a patient's anatomy. In particular, in preferred embodiments, the curve is chosen to correspond to the curvature of a patient's rib, allowing less traumatic passage through the subcutaneous space of a patient along the patient's chest.

The tool 40 includes a shaft portion 42 that is preferably stiff enough to provide pushability to a distal end 44 for creating a path through tissue. In several embodiments, a relatively rigid metallic member, such as a stainless steel shaft, is used for the shaft portion 42. The shaft 42 is secured to a handle 46 near its proximal end, where a Luer connector 48 is provided. Instead of a metallic member, a pushable polymeric member may be used, or, alternatively, a braided shaft member including polymeric layers and a braided support structure.

The distal end 44 of the shaft 42 illustrates a couple of attachment features, including a groove 50 and a suture hole 52. For example, the groove 50 may be a radial groove allowing for slipknot attachment to a thread such as a suture. The suture hole 52 may allow for a thread or suture to be passed therethrough and then tied. In another embodiment, a staple may pass through the hole 52 such that, rather than having a person physically tie or knot a suture, a surgical stapler may be used instead.

Referring to FIG. 3B, the tool 40 is shown in section or cut-away view with the shaft 42 extending through the handle 46. The shaft 42 defines a lumen 54 that extends from the Luer connector 48 to an infusion port opening into the suture hole 52. The handle 46 may be secured to shaft 42 in any suitable way, for example, with adhesives, mechanical securing devices (i.e., threads, notches, or the like), heat welding, or by overmolding the handle 46 onto the shaft 42. One way to improve the mechanical strength of the bond is to include an offset bend 56 in the shaft 42 under the handle 46.

FIGS. 4A-4C show detailed section views of an electrode insertion tool handle. The electrode insertion tool handle 60 may correspond to the handles 26, 46 illustrated in FIGS. 2A-2B and 3A-3B. The handle 60 includes a Luer port 62 for providing access to a lumen defined by the shaft 66. As shown in FIG. 4B, the Luer port/valve 62 includes a proximal securing portion 70 for securing to, for example, a fluid infusion device, and a distal securing portion 72 for securing to the shaft 66.

In an illustrative example, a local anesthetic such as lidocaine may be infused. Other anesthetics, anti-infection drugs, or drugs designed/chosen to prevent or limit swelling or other tissue injury responses may be infused as well. An advantage of providing a medication limiting tissue injury response may be to limit the size of any tissue growth around an implanted lead. Alternatively, for example to ensure good anchoring of a lead, a substance designed to cause or maximize local tissue injury response may be provided. Additionally, certain tissue adhesives could also be delivered through the lumen.

The main handle portion 64, as seen in FIGS. 4A and 4C may be designed to have a flattened side and a wider side. This design aids a doctor/practitioner in grasping the device during tunneling and pulling with the shaft 66, as well as providing space for the offset bend 68 shown in FIG. 4A. The offset bend 68 of the shaft 66 aids in anchoring the shaft 66 in the main handle portion 64. Other handle designs may be used in accordance with the present invention.

FIGS. 5A-5B show, in perspective and section views, details of an electrode insertion tool tip. The tip 80 may correspond to the distal ends 24, 44 illustrated in FIGS. 2A-2B and 3A-3B. The tip 80 includes a rounded end 82 which may have a “bullet” shape for tunneling between tissue layers while avoiding tunneling through tissue layers. In a preferred embodiment, the rounded end 82 is tapered to allow tunneling into fatty subcutaneous tissue without perforating the skin. Also included are two illustrative attachment features, including a suture hole 84 and a radial groove 86 allowing for suture attachment using, for example, a slipknot.

The tip 80 with end 82, suture hole 84 and groove 86 is also shown in FIG. 5B. Also shown in FIG. 5B is a lumen 88 that terminates in an infusion port that opens laterally through the suture hole 84. With this structure, the suture hole 84 serves two functions, both as an attachment feature and as an extension of the infusion port. The lumen 88 extends through the rest of the shaft (not shown) to a handle and Luer valve such as those shown in FIGS. 2A-2B and 3A-3B.

FIGS. 6A-6C show perspective and alternative detail views of a lead electrode assembly. The lead electrode assembly 90 is shown as having a number of electrodes, including a coil electrode 92 and two sense electrodes 94. The assembly 90 has a distal tip 96. As shown in FIG. 6A and further illustrated in FIG. 6B, the distal tip 96 may include a suture hole 98, although any other attachment feature may be used, such as a radial groove as shown in FIGS. 5A-5B or a hook/notch 98′ as shown in FIG. 6C in association with tip 96′. For a radial groove 86 or a hook/notch 98′, a loop of suture material (or string, for example) or a staple may be secured to the distal tip 96, 96′ by tightening the loop into the groove 86 or hook/notch 98′. The inclusion of a coil electrode 92 and two sense electrodes 94 is merely illustrative of one lead electrode assembly that may be inserted with the aid of the methods/devices of the present invention.

FIG. 7 shows a perspective view of an insertion tool bending device. The bending device 100 includes posts 102 separated by a gap 104. To bend a device such as the shaft of the insertion tools 20, 40 shown in FIGS. 2A-2B or 3A-3B, the shaft of the chosen device is passed through the gap 104 and turned with respect to the bending tool 100, allowing the posts 102 to reshape the device with a different curve. This may be done to match a chosen insertion tool more accurately to a patient's anatomy. The posts 102 may be modified by including caps, notches, grooves, hooks, overhangs or the like for retaining a device shaft going through the gap 104 to prevent it from slipping out.

FIG. 8 shows a perspective partial view of an infusion tubing set. The tubing set 110 may be used in conjunction with one of the insertion tools 20, 40 shown in FIGS. 2A-2B or 3A-3B. The tubing set 110 is used to provide a flexible extension enabling easy attachment of a fluid infusion device to the Luer valve of a chosen insertion tool. The tubing set 110 includes first and second connectors 112, 114 and a flexible tubular shaft 116 therebetween.

FIGS. 9A-9B show, in combination and alone, an insertion tool with a splittable sheath and a splittable sheath by itself. FIG. 9A illustrates an insertion tool 150 having a handle 152 and a shaft 154 extending to a distal tip 156, with a splittable sheath 158 disposed thereon. The splittable sheath 158 is sized to snugly fit over the shaft 154, and is preferably shorter than the shaft 154 such that the distal end 156 can extend distally of the splittable sheath 158.

As further shown in FIG. 9B, the splittable sheath 158 has a proximal handle portion 160 and a distal end 162. The distal end 162 may be tapered or thinned such that there is no leading “shoulder” during insertion to tissue. Preferably, the splittable sheath 158 is thin enough that the distal end 162 of the splittable sheath 158 does not create significant drag during insertion, and does not require thinning, grinding, or the like.

Alternatively, though not shown in FIG. 9A, the insertion tool 150 may include a proximally facing lip near its distal end for seating the distal end of the splittable sheath 152. Such a proximally facing lip may be provided by preloading the splittable sheath 152 on the shaft and then providing an overlay or separate tip that can be secured (i.e., by heating, welding or adhesive) to the distal end of the shaft. In another embodiment (referring again to FIG. 9B), the distal end 162 of the splittable sheath 158 may be ground to smooth out the distal shoulder. The splittable sheath 158 also includes a region of longitudinal weakness 164 for splitting the handle 160, which also extends toward the distal end 162, allowing for splitting of the sheath itself.

FIG. 10 shows a patient illustrating relative positions for incisions in an example procedure. The patient 200 is shown with the median plane 202 defined and a rough illustration of the heart 204 provided. Incision locations for a first incision 206 and a second incision 208 are shown, again as a relatively rough approximation. Preferably the incisions 206, 208 both lie over the same rib or between the same pair of ribs of the patient 200. Each incision is deep enough to enable subcutaneous access, but preferably does not extend further into patient 200. Such incisions may be made over any of the patients ribs, but are preferably made somewhere between the third and twelfth ribs of the patient. In another preferred embodiment, the line from the first incision to the second incision tracks, at least partly, the inframammary crease. The second incision is also preferably made in the region of the left anterior axillary line. While these are presently preferred locations, the specific locations of each incision may vary widely within the context of the present invention.

FIGS. 11A-11J show an illustrative method of electrode insertion. FIG. 11A illustrates a first step after the making of a first incision 206 and a second incision 208 in a patient 200. Note also that a pocket 207 has been defined in the subcutaneous region of the patient 200. The pocket 207 may be formed by inserting a trocar through the second incision and separating tissue layers with the trocar to define a subcutaneous pocket 207 or by using manual blunt dissection for receipt of an implantable device. An insertion tool 210 (illustrated as including a splittable sheath 218 thereon) is about to be inserted through the first opening 206. As shown in FIG. 11B, the insertion tool 210 is advanced from the first opening 206 toward and through the second opening, tunneling a path through the subcutaneous tissue along the way. While advancement of the distal end 212 through the second incision 208 is shown, this extent of insertion is not necessary. It is sufficient that the insertion tool 210 is advanced far enough to provide access from outside of incision 208 to the distal end 212 of the insertion tool 210 for access to an attachment feature. The attachment feature shown in FIG. 11B is shown, for illustrative purposes, as including a suture hole 216. During such insertion and tunneling, a local anesthetic such as Lidocaine or the like may be supplied by infusion through a Luer hub 214 and passage through a lumen in the insertion tool 210.

As shown in FIG. 11C, a next step includes attaching the distal end of a lead electrode assembly 220 to the distal end 212 of the insertion tool 210 using a suture loop 224 that passes through the insertion tool 210 suture hole 216 and a corresponding suture hole 222 on the lead electrode assembly 220. The illustrative lead electrode assembly 220 is shown having two sensing and one shocking electrode thereon; such a configuration is merely illustrative of one lead assembly, and use of the present invention need not be limited to such electrode lead assemblies.

Instead of suture holes 216, 222, other attachment features such as hooks or radial grooves, as illustrated above, may be used. Magnetic, screw-type, locking ball, snap fit, or other types of attachment may be substituted as well, though for the purposes of illustration, magnetic, screw-type, locking ball and snap fit attachment features have not been shown herein. It is sufficient that the attachment feature enable attachment of the insertion tool distal end to another element such as a lead electrode assembly. Advantageously, the suture holes, hooks or radial grooves allow for relatively simple and reliable attachment using readily available (and strong) suture material or staples. In particular, attaching a suture or staple is relatively simple. For sutures, any type of knot may be used, from simple slipknots to many stronger and more complex knots, to achieve a strong attachment. Removal is also simple, easy, and foolproof, being performed by merely cutting the suture/staple 224.

Referring now to FIG. 11D, a next step is illustrated wherein the insertion tool 210 is withdrawn through the first incision 206, pulling the lead electrode assembly 220 into the path tunneled by the insertion tool 210 between the incisions 206, 208 using the suture 224 and suture holes 216, 222. As shown, this step is performed until at least the suture 224 can be accessed from outside the patient.

In one embodiment of the present invention, the method may stop here. With the lead electrode assembly 220 pulled into the path between the incisions 206, 208, the lead assembly 220 may be sized such that a canister 230 attached to the proximal end of the lead electrode assembly 220 is pulled into the pocket 207. The suture 224 is then cut and the incisions 206, 208 sewn shut, such that implantation is essentially complete insofar as device placement is concerned. Because the lead assembly 220 is pulled into position after tunneling, rather than being carried or pushed into position, the resultant strains on the lead assembly 220 are reduced. Further, by advancing from a first incision 206 at a definite location to a second incision 208 at another definite location, both ends of the path so defined can be tightly controlled. Thus, placement inaccuracy is avoided.

An alternative embodiment continues in FIGS. 11E-11J. After the step of FIG. 11D, as shown in FIG. 11E, the lead electrode assembly 220 is pulled for a greater distance allowing access to the distal end 222 thereof. The lead assembly 220 may be pulled sufficiently to cause it to exit the first incision 206 by a certain amount. Then, as shown in FIG. 11F, the insertion tool 210 with the splittable sheath 218 is re-inserted into the first incision 206, this time in a different direction than before. In an alternative embodiment, a first, preferably curved, insertion tool is used during the steps shown in FIGS. 11A-11E while a second, preferably straight, insertion tool is used in FIGS. 11F-11J, with the splittable sheath provided only for the straight insertion tool.

As shown in FIG. 11G, the insertion tool 210 is inserted via the first incision 206 toward a chosen point or location X 232 located cephalic (directed toward the head of the patient) of the first incision. Preferably, a line drawn from the first incision 206 to the second incision 208 is at an angle θ, between about 20 and 160 degrees, with respect to a line drawn from the first incision toward location X 232. More preferably, the angle θ is around about 90 degrees, being in the range of between 75 and 105 degrees.

After the insertion tool 210 has tunneled a desired distance, and while the splittable sheath 218 may still be accessed from outside the patient, the insertion tool 210 is removed to leave the splittable sheath 218 in place, as shown in FIG. 11H. Next, the distal end of the lead electrode assembly 220 is directed into the splittable sheath 218, as also shown in FIG. 11H. Once the lead assembly 220 is directed into the splittable sheath 218 to a desired distance, the splittable sheath 218 may be removed by grasping handles 234 and tearing the sheath apart, as shown in FIG. 11I. At this point, as shown in FIG. 11I, the lead assembly 220 is preferably far enough into the patient longitudinally that the canister 230 has entered the pocket 207 and is inside the patient 200, through incision 208. As shown at FIG. 11J, the incisions 206, 208 are then closed, leaving the lead electrode assembly 220 and canister 230 fully implanted. After this point, the implantation is complete, and a variety of methods may be used to “activate” and/or program the canister 230 and whatever electronics for pacing and/or defibrillation are contained therein.

An advantage of the configuration for implantation of the electrode assembly shown in FIG. 11J is that the electrodes on the lead electrode assembly 220 are aligned in a new manner with respect to the canister 230. In prior art devices, the canister 230 was often generally collinear with the electrodes on the lead electrode assembly. An electrode on the canister 230 may be offset from the axial direction of the lead electrode assembly, allowing for some minor angular variation in exchange for reducing the distance between electrodes. Even if there were more than two sensing electrodes, the signals received by distinct sensing electrode pairs would have little variation, since collinear electrodes generally do not receive significantly different signals in the far-field, except for pairs that are close together and therefore yield poor signal anyway. The assembly inserted as shown in FIG. 11J enables multiple sensors on the distal end of the lead assembly 220, along with at least one canister electrode, to provide a wider variation in angular orientation, without closing the distance between the canister and the electrodes.

FIGS. 12A-12B help to further illustrate several relevant sensor characteristics. It should be recognized that, at least with far-field sensing of electrical activity in the heart, parallel sensor pairs tend to receive highly correlated signals. Over a short distance, there is little to be gained by having more than two sensors along the same line. Given a sensing lead electrode assembly and canister device as shown and oriented in FIG. 12A, dead signal sensing problems can arise.

Given sensor X on a canister 300, and sensors Y and Z on the lead electrode assembly 302, the primary difficulty arises when the need for backup sensing is greatest. In particular, if a minimal signal is sensed between a first sensor pair XY, a similarly minimal signal will be received by sensor pair YZ as well as signal pair XZ, since the three electrodes are collinear. If the minimal received signal is too close to the noise floor, then the sensors will fail to provide adequate data for reliable QRS detection, let alone sufficient information to provide pacing or defibrillating assistance. Even if X is offset from the line of the lead electrode assembly 302, the angular distinctions between pairs XY, XZ and YZ are quite small.

As shown in FIG. 12B, three sensors X, Y, and Z on a lead assembly 312 coupled to a canister 310 define three sensor pair vectors 314, 316, and 318 which have angles α, β, and γ therebetween. The above problem is avoided when the electrodes X, Y, and Z are not generally collinear, as shown. Angles α, β and γ are all relatively large, each being bigger than about fifteen degrees. If orthogonal sensing pairs are used, when the minimum signal is received by one of the pairs, a maximum signal is received by the other pair. While the vectors of XY, XZ and YZ are not exactly orthogonal, their deviation from being collinear is sufficient to eliminate the problems that arise with the configuration of FIG. 12A. When sensor backup is most needed (minimum signal received by one pair), the configuration or layout of FIG. 12B provides excellent backup.

In another embodiment (relying on another form of analysis), the insertion method is performed so that three sensors define a plane which at least partly intersects the heart. In yet another embodiment, sensors are placed so that at least one angle between sensor pair vectors is greater than 30 degrees. More preferably, at least one angle between sensor pair vectors is greater than about 60 degrees, while most preferably at least one angle between sensor pair vectors is in the range of about 70-90 degrees. Note that when referring to angles between sensor pair vectors, the angles referred to are the lesser angles between pairs of intersecting vectors. Another preferred layout is one in which the sine of the angles between sensing vectors is intentionally increased, preferably so that the sine of at least one such angle between sensing vectors is greater than or equal to about 0.5.

The layout of FIG. 12B illustrates only three sensors for the purpose of simplicity. It may be preferable to include four electrodes, with one canister electrode being both a sensing and a shocking electrode, while two lead electrodes are only sensing electrodes provided distal of and proximal of a shocking/sensing electrode coil. Indeed, unless specifically limited by the use of non-inclusive language in the following claims, the number of sensors used in a lead electrode assembly should not be understood as limiting the present invention.

Those skilled in the art will recognize that the present invention may be manifested in a variety of forms other than the specific embodiments described and contemplated herein. Accordingly, departures in form and detail may be made without departing from the scope and spirit of the present invention as described in the appended claims.

Claims

1. A method of inserting a lead electrode assembly subcutaneously into a patient, the method comprising:

making a first incision;
making a second incision spaced from the first incision;
advancing a tool having proximal and distal ends through the first incision toward the second incision, the distal end of the tool being adapted for dissecting tissue, wherein the tool is advanced by dissecting tissue with the distal end of the tool;
securing the lead electrode assembly to the tool near the distal end of the tool near the second incision;
withdrawing the tool through the first incision such that the lead electrode assembly is pulled into the patient through the second incision via a first subcutaneous path;
advancing the tool along a second subcutaneous path through the first incision toward a chosen subcutaneous location;
withdrawing the tool from the second subcutaneous path; and
inserting a length of the lead electrode assembly that has been passed into the patient through the second incision and toward the first incision via the first subcutaneous path along the second subcutaneous path:
wherein:
during the step of advancing the tool from the first incision toward the second incision, a splittable sheath is secured onto the tool;
during the step of withdrawing the tool through the first incision such that the lead electrode assembly is pulled into the patient through the second incision, the splittable sheath continues to be secured onto the tool;
during the step of advancing the tool along the second subcutaneous path through the first incision toward the chosen subcutaneous location, the splittable sheath is disposed over the tool;
during the step of withdrawing the tool from the second subcutaneous path, the splittable sheath is retained in place along the the tool, the splittable sheath is retained in place along the second subcutaneous path and is no longer secured to the tool; and
the step of inserting the length of lead electrode assembly along the second subcutaneous path includes the length of lead electrode assembly along the path includes advancing a distal end of the lead electrode assembly into the splittable sheath.

2. The method of claim 1, wherein:

the first incision is along the patient's sternum relatively near the patient's median plane; and
the second incision is laterally spaced from the first incision.

3. The method of claim 1, wherein:

the first incision is along the patient's sternum relatively near the patient's median plane;
the second incision is laterally spaced from the first incision; and
the chosen subcutaneous location is located cephalic of the first incision.

4. The method of claim 1, further comprising the step of removing the splittable sheath from the second subcutaneous path while maintaining the length of the lead electrode assembly at least partly in a position along the second subcutaneous path.

5. The method of claim 1, wherein the tool is configured to enable fluid infusion therethrough, the method further including infusing a fluid into the patient with the tool.

6. The method of claim 5, wherein the fluid is a local anesthetic.

7. The method of claim 5, wherein the fluid is a tissue adhesive.

8. The method of claim 1, wherein the tool includes an attachment feature near its distal end, wherein the step of securing the lead electrode assembly to the tool includes using the attachment feature to attach to the lead electrode assembly.

9. The method of claim 8, wherein the attachment feature includes a suture hook, wherein the step of securing the lead electrode assembly to the tool includes securing a suture to the suture hook.

10. The method of claim 8, wherein the attachment feature includes a suture hole, wherein the step of securing the lead electrode assembly to the tool includes passing a suture through the suture hole and thereby securing the suture to the tool.

11. The method of claim 10, wherein the tool includes a fluid infusion lumen therethrough, the fluid infusion lumen opening into the suture hole, the method further comprising infusing a fluid into the patient through the fluid infusion lumen.

12. The method of claim 8, wherein the attachment feature includes a groove enabling a suture to be attached to the tool, wherein the step of securing the lead electrode assembly includes attaching a suture to the tool using the groove.

13. A method of subcutaneously inserting a lead electrode assembly into a patient comprising:

making a first incision in the patient's torso;
making a second incision in the patient's torso;
providing a tool having proximal and distal ends with a splittable sheath disposed thereon;
advancing the tool and sheath through the first incision toward the second incision;
advancing the distal end of the tool through the second incision;
securing the lead electrode assembly to the distal end of the tool;
withdrawing the tool through the first incision such that the lead electrode assembly is pulled into the patient through the second incision, and
pulling the lead assembly through the first incision until a first length of the lead assembly extends out of the first incision;
wherein the method includes retaining the splittable sheath in a fixed position on the tool at least until a portion of the lead electrode is drawn through the first incision.

14. The method of claim 13, further comprising:

after pulling the lead assembly through the first incision until a first length of the lead assembly extends out of the first incision, advancing the tool and sheath through the first incision to a chosen subcutaneous location spaced from both the first incision and the second incision, creating a subcutaneous path from the first incision to the chosen subcutaneous location;
withdrawing the tool while maintaining the splittable sheath in place;
advancing the first length of the lead assembly into the sheath; and
withdrawing the sheath while maintaining the first length of the lead assembly in place in the subcutaneous path.

15. The method of claim 14, wherein the step of withdrawing the sheath includes splitting the sheath along an axial line of weakness.

16. The method of claim 13, wherein the tool is configured to enable fluid infusion therethrough, the method further including infusing a fluid into the patient with the tool.

17. The method of claim 13, wherein the tool includes an attachment feature near its distal end, wherein the step of securing the lead electrode assembly to the tool includes using the attachment feature to attach to the lead electrode assembly.

18. The method of claim 17, wherein the attachment feature includes a suture hook, wherein the step of securing the lead electrode assembly to the tool includes securing a suture to the suture hook.

19. The method of claim 17, wherein the attachment feature includes a suture hole, wherein the step of securing the lead electrode assembly to the tool includes passing a suture through the suture hole and thereby securing the suture to the tool.

20. The method of claim 19, wherein the tool includes a fluid infusion lumen therethrough, the fluid infusion lumen opening into the suture hole, the method further comprising infusing a fluid into the patient through the fluid infusion lumen.

21. The method of claim 17, wherein the attachment feature includes a groove enabling a suture to be attached to the tool, wherein the step of securing the lead electrode assembly includes attaching a suture to the tool using the groove.

Referenced Cited
U.S. Patent Documents
3653387 April 1972 Ceier
3710374 January 1973 Kelly
3911925 October 1975 Tillery, Jr.
4030509 June 21, 1977 Heilman et al.
4157720 June 12, 1979 Greatbatch
4164946 August 21, 1979 Langer
4184493 January 22, 1980 Langer et al.
4191942 March 4, 1980 Long
4210149 July 1, 1980 Heilman et al.
RE30387 August 26, 1980 Denniston, III et al.
4223678 September 23, 1980 Langer et al.
4248237 February 3, 1981 Kenny
4254775 March 10, 1981 Langer
4270549 June 2, 1981 Heilman
4291707 September 29, 1981 Heilman et al.
4300567 November 17, 1981 Kolenik et al.
4314095 February 2, 1982 Moore et al.
4375817 March 8, 1983 Engle et al.
4402322 September 6, 1983 Duggan
4407288 October 4, 1983 Langer et al.
4424818 January 10, 1984 Doring et al.
4450527 May 22, 1984 Sramek
4548209 October 22, 1985 Weilders et al.
4567900 February 4, 1986 Moore
4595009 June 17, 1986 Leinders
4596559 June 24, 1986 Fleischhacker
4602637 July 29, 1986 Elmqvist et al.
4603705 August 5, 1986 Speicher et al.
4693253 September 15, 1987 Adams
4727877 March 1, 1988 Kallok
4750494 June 14, 1988 King
4765341 August 23, 1988 Mower et al.
4768512 September 6, 1988 Imran
4800883 January 31, 1989 Winstrom
4830005 May 16, 1989 Woskow
4944300 July 31, 1990 Saksena
5044374 September 3, 1991 Lindemans et al.
5105810 April 21, 1992 Collins et al.
5105826 April 21, 1992 Smits et al.
5109842 May 5, 1992 Adinolfi
5129392 July 14, 1992 Bardy et al.
5133353 July 28, 1992 Hauser
5144946 September 8, 1992 Weinberg et al.
5184616 February 9, 1993 Weiss
5191901 March 9, 1993 Dahl et al.
5203348 April 20, 1993 Dahl et al.
5215081 June 1, 1993 Ostroff
5230337 July 27, 1993 Dahl et al.
5255692 October 26, 1993 Neubauer et al.
5261400 November 16, 1993 Bardy
5300106 April 5, 1994 Dahl et al.
5313953 May 24, 1994 Yomtov et al.
5331966 July 26, 1994 Bennett et al.
5342407 August 30, 1994 Dahl et al.
5366496 November 22, 1994 Dahl et al.
5376103 December 27, 1994 Anderson et al.
5376104 December 27, 1994 Sakai et al.
5385574 January 31, 1995 Hauser et al.
5391200 February 21, 1995 KenKnight et al.
5405337 April 11, 1995 Maynard
5405363 April 11, 1995 Kroll et al.
5411539 May 2, 1995 Neisz
5411547 May 2, 1995 Causey, III
5413591 May 9, 1995 Knoll
5423326 June 13, 1995 Wang et al.
5439485 August 8, 1995 Mar et al.
5447521 September 5, 1995 Anderson et al.
5476503 December 19, 1995 Yang
5509923 April 23, 1996 Middleman et al.
5509928 April 23, 1996 Acken
5531765 July 2, 1996 Pless
5531766 July 2, 1996 Kroll et al.
5534019 July 9, 1996 Paspa
5534022 July 9, 1996 Hoffmann et al.
5589563 December 31, 1996 Ward et al.
5597956 January 28, 1997 Ito et al.
5601607 February 11, 1997 Adams
5603732 February 18, 1997 Dahl et al.
5607455 March 4, 1997 Armstrong
5618287 April 8, 1997 Fogarty et al.
5620477 April 15, 1997 Pless et al.
5643328 July 1, 1997 Cooke et al.
5645586 July 8, 1997 Meltzer
5658317 August 19, 1997 Haefner et al.
5658319 August 19, 1997 Kroll
5658321 August 19, 1997 Fayram et al.
5665093 September 9, 1997 Atkins et al.
5674260 October 7, 1997 Weinberg
5683447 November 4, 1997 Bush et al.
5690648 November 25, 1997 Fogarty et al.
5690683 November 25, 1997 Haefner et al.
5693081 December 2, 1997 Fain et al.
5697953 December 16, 1997 Kroll et al.
5713926 February 3, 1998 Hauser et al.
5766226 June 16, 1998 Pedersen
5776169 July 7, 1998 Schroeppel
5782841 July 21, 1998 Ritz et al.
5814090 September 29, 1998 Latterell et al.
5827326 October 27, 1998 Kroll et al.
5836976 November 17, 1998 Min et al.
5843031 December 1, 1998 Hermann et al.
5843132 December 1, 1998 Ilvento
5895414 April 20, 1999 Sanchez-Zambrano
5904705 May 18, 1999 Kroll et al.
5919211 July 6, 1999 Adams
5919222 July 6, 1999 Hjelle et al.
5925069 July 20, 1999 Graves et al.
5935154 August 10, 1999 Westlund
5938603 August 17, 1999 Ponzi
5941904 August 24, 1999 Johnston et al.
5957956 September 28, 1999 Kroll et al.
6014586 January 11, 2000 Weinberg et al.
6026325 February 15, 2000 Weinberg et al.
6058328 May 2, 2000 Levine et al.
6093173 July 25, 2000 Balceta et al.
6095987 August 1, 2000 Shmulewitz et al.
H1905 October 3, 2000 Hill
6128531 October 3, 2000 Campbell-Smith
6144866 November 7, 2000 Miesel et al.
6144879 November 7, 2000 Gray
6148230 November 14, 2000 KenKnight
6183485 February 6, 2001 Thomason et al.
6185450 February 6, 2001 Seguine et al.
6215231 April 10, 2001 Newnham et al.
6254568 July 3, 2001 Ponzi
6266567 July 24, 2001 Ishikawa et al.
6278894 August 21, 2001 Salo et al.
6280462 August 28, 2001 Hauser et al.
6324414 November 27, 2001 Gibbons et al.
6327492 December 4, 2001 Lemelson
6332089 December 18, 2001 Acker et al.
6334071 December 25, 2001 Lu
6340588 January 22, 2002 Nova et al.
6345198 February 5, 2002 Mouchawar et al.
6348045 February 19, 2002 Malonek et al.
6360130 March 19, 2002 Duysens et al.
6411844 June 25, 2002 Kroll et al.
6605094 August 12, 2003 Mann et al.
6647292 November 11, 2003 Bardy et al.
6671554 December 30, 2003 Gibson et al.
6721597 April 13, 2004 Bardy et al.
6752827 June 22, 2004 Ross et al.
6754528 June 22, 2004 Bardy et al.
6778860 August 17, 2004 Ostroff et al.
6788974 September 7, 2004 Bardy et al.
6834204 December 21, 2004 Ostroff et al.
6865417 March 8, 2005 Rissmann et al.
6866044 March 15, 2005 Bardy et al.
20010027330 October 4, 2001 Sullivan et al.
20020188252 December 12, 2002 Bardy
20030045892 March 6, 2003 Kaladelfos
20040186529 September 23, 2004 Bardy et al.
20040254611 December 16, 2004 Palreddy et al.
20040254613 December 16, 2004 Ostroff et al.
20040260370 December 23, 2004 Ley et al.
20050049644 March 3, 2005 Warren et al.
Foreign Patent Documents
298 01 807 July 1998 DE
0 095 727 December 1983 EP
0 316 616 May 1989 EP
0 316 616 May 1989 EP
0 347 353 December 1989 EP
0 517 494 December 1992 EP
0 517 494 December 1992 EP
0 518 599 December 1992 EP
0 518 599 December 1992 EP
0 536 873 April 1993 EP
0 586 858 March 1994 EP
0 627 237 December 1994 EP
0 641 573 March 1995 EP
0 641 573 March 1995 EP
0 677 301 October 1995 EP
0 917 887 May 1999 EP
0 923 130 June 1999 EP
1 000 634 May 2000 EP
WO 93/19809 October 1993 WO
WO 97/29802 August 1997 WO
WO 98/25349 June 1998 WO
WO 99/03534 January 1999 WO
WO 99/37362 July 1999 WO
WO 99/53991 October 1999 WO
WO 00/41766 July 2000 WO
WO 00/50120 August 2000 WO
WO 01/43649 June 2001 WO
WO 01/56166 August 2001 WO
WO 02/22208 March 2002 WO
WO 02/22208 March 2002 WO
WO 02/24275 March 2002 WO
WO 02/24275 March 2002 WO
WO 02/068046 September 2002 WO
WO 03/018121 March 2003 WO
WO 03/022352 March 2003 WO
WO 03/039666 May 2003 WO
Other references
  • Bardy, Gust H. et al., “Multicenter Experience with a Pectoral Unipolar Implantable Cardioverter-Defibrillator,” JACC, Aug. 1996, vol. 28, No. 2, pp. 400-410.
  • Friedman, Richard A. et al., “Implantable Defibrillators In Children: From Whence to Shock,” Journal of Cardiovascular Electrophysiology, vol. 12, No. 3, Mar. 2001, pp. 361-362.
  • Gradaus, Rainer et al., “Nonthoracotomy Implantable Cardioverter Defibrillator Placement in Children: Use of Subcutaneous Array Leads and Abdominally Placed Implantable Cardioverter Defibrillators in Children,” Journal of Cardiovascular Electrophysiology, vol. 12, No. 3, Mar. 2001, pp. 356-360.
  • Higgins, Steven L. et al., “The First Year Experience with the Dual Chamber ICD,” PACE, Jan. 2000, vol. 23, pp. 18-25.
  • Mirowski, M. et al., “Automatic Detection and Defibrillation of Lethal Arrhythmias-A New Concept,” JAMA, vol. 213, No. 4, Jul. 27, 1970, pp. 615-616.
  • Olson, Walter H. et al., “Onset and Stability for Ventricular Tachyarrhythmia Detection in an Implantable Pacer-Cardioverter-Defibrillator,” IEEE, (1987) pp. 167-170.
  • Schuder, John C., “Completely Implanted Defibrillator,” JAMA, vol. 214, No. 6, Nov. 9, 1970. p. 1123 (single sheet).
  • Schuder, John C. et al., “Experimental Ventricular Defibrillation with an Automatic and Completely Implanted System,”Trans. Amer. Soc. Artif. Int. Organs, vol. XVI (1970) pp. 207-212.
  • Schuder, John C., “The Role of an Engineering Oriented Medical Research Group in Developing Improved Methods and Devices for Achieveing Ventricular Defibrillation: The University of Missouri Experience,” PACE, vol. 16, Jan. 1993, pp. 95-124.
  • Schuder, John C. et al., “Standby Implanted Defibrillators,” Arch Intern. Med, vol. 127, Feb. 1971, p. 317 (single sheet).
  • Schuder, John C. et al., “Transthoracic Ventricular Defibrillation in the Dog with Truncated and Untruncated Exponential Stimuli,” IEEE Transactions on Bio-Medical Engineering, vol. BME-18, No. 6, Nov. 1971, pp. 410-415.
  • Schwacke, H. et al., “Komplikation mit Sonden bei 340 Patienten mit einem Implantierbaren Kardioverter/Defibrillator,” Z Kardiol (1999)vol. 88, No. 8, pp. 559-565.
  • Tietze U. et al., “Halbleiter-Schaltungstechnik,” © Springer-Verlag (Berlin, Germany), (1991), pp 784-786.
  • Valenzuela, Terrence D. et al., “Outcomes of Rapid Defibrillation by Security Officers After Cardiac Arrest in Casinos,” The New England Journal of Medicine, Oct. 26, 2000, vol. 343, No. 17, pp. 1206-1209.
  • Walters, R.A. et al., “Analog to Digital Conversion Techniques in Implantable Devices,” Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 13 No. 4 (1991) p. 1674-1676.
Patent History
Patent number: 7655014
Type: Grant
Filed: Dec 6, 2004
Date of Patent: Feb 2, 2010
Patent Publication Number: 20060122676
Assignee: Cameron Health, Inc. (San Clemente, CA)
Inventors: Michael Ko (Mission Viejo, CA), Duane Tumlinson (San Clemente, CA)
Primary Examiner: Todd E Manahan
Assistant Examiner: Eric Blatt
Attorney: Pramudji Wendt & Tran, LLP
Application Number: 11/006,291
Classifications
Current U.S. Class: Electrode Guide Means (606/129)
International Classification: A61B 19/00 (20060101);